BioSensus is pioneering the use of miniaturized acoustic sensing technology licensed from Drexel University to enable healthcare workers and patients to conduct diagnostic and therapeutic monitoring at the bedside and at home (self-testing), using a small and inexpensive hand-held device. In its first application, the company's revolutionary NanoAcoustic Blood Analyzer (NABA) will measure blood coagulation properties, clotting times, and platelet function from a single finger stick, similar to that used by diabetics for monitoring blood glucose.
- "Company Thinks Big with Small Products" - article from the Philadelphia Business Journal, March 19, 2004 [Download as Adobe PDF]
- "At-Home Device Would Check Blood Thinning" - article from the Associated Press, March 8, 2004 [Download as Adobe PDF]
- "BioSensus Raising $3M in First Institutional Round After BioAdvance Funds " - article from the Dow Jones VenureWire Professional, February 20, 2004 [Download as Adobe PDF]
- BioAdvance Press Release, February, 2004 [Download as Adobe PDF]
- Drexel University Press Release, February 11, 2004 [Download as Adobe PDF]